Pharming Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	-	54.94	61.74	207.34	191.92	205.16
Short-Term Investments	-	112.95	151.68	-	-	-
Cash & Short-Term Investments	168.9	167.89	213.42	207.34	191.92	205.16
Cash Growth	-1.67%	-21.33%	2.93%	8.03%	-6.45%	175.94%
Accounts Receivable	-	54.82	46.16	27.62	29.98	35.9
Inventory	-	55.72	56.76	42.33	27.31	21.16
Other Current Assets	-	-	-	0.21	0.23	1
Total Current Assets	277.6	278.44	316.34	277.5	249.44	263.21
Net Property, Plant & Equipment	-	24.13	33.47	39.15	33.17	21.65
Other Intangible Assets	-	61.04	71.27	75.12	83.83	94.08
Long-Term Investments	-	4.23	10.4	9.73	8.65	7.12
Other Long-Term Assets	-	32.14	31.38	24.3	22.22	32.39
Total Assets	473.8	399.99	462.85	425.8	397.32	418.45
Accounts Payable	-	66.61	72.53	54.47	42.47	47.67
Current Portion of Long-Term Debt	-	4.25	1.82	1.77	1.88	2.04
Current Portion of Leases	-	2.95	3.62	3.47	2.42	1.96
Other Current Liabilities	-	-	-	-	-	25.18
Total Current Liabilities	67.1	73.8	77.97	59.7	46.77	76.85
Long-Term Debt	-	78.15	136.6	131.62	139.01	149.73
Long-Term Leases	-	26.97	29.51	29.84	18.46	8.23
Other Long-Term Liabilities	-	-	-	-	0.17	0.21
Total Long-Term Liabilities	-	105.12	166.11	161.46	157.63	158.17
Total Liabilities	67.1	178.92	244.07	221.16	204.4	235.02
Common Stock	-	7.77	7.67	7.51	7.43	7.31
Additional Paid-in Capital	-	488.99	478.43	462.3	455.25	447.13
Accumulated Other Comprehensive Income	-	-0.21	-2.06	-8.74	3.4	24.61
Retained Earnings	-	-275.49	-265.26	-256.43	-273.17	-295.62
Shareholders' Equity	-	221.06	218.78	204.64	192.92	183.44
Total Liabilities & Equity	67.1	399.99	462.85	425.8	397.32	418.45
Total Debt	-	112.31	171.55	166.69	161.76	161.96
Net Cash (Debt)	168.9	55.58	41.88	40.65	30.16	43.2
Net Cash Growth	203.89%	32.72%	3.03%	34.76%	-30.18%	167.52%
Net Cash Per Share	-	0.71	0.58	0.57	0.43	0.63
Book Value	-	221.06	218.78	204.64	192.92	183.44
Book Value Per Share	-	2.81	3.02	2.89	2.75	2.69
Tangible Book Value	-	160.02	147.51	129.52	109.08	89.35
Tangible Book Value Per Share	-	2.04	2.03	1.83	1.56	1.31

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q